Top Markets
Coin of the day
Moleculin Biotech, Inc. Moleculin Biotech, Inc.

Moleculin Biotech, Inc.

MBRX
Rank in Stocks #35911
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to... Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections. Their primary investigational drug, Annamycin, is currently undergoing Phase 1/2 clinical trials. These trials aim to assess its efficacy against acute myeloid leukemia (AML) that has relapsed or is resistant to prior therapies, as well as malignancies that have spread to the lungs. WP1066, a prominent immune/transcription modulator for the company, is presently in Phase I studies, targeting both adult and pediatric brain tumors, pancreatic cancer, and other types of aggressive malignancies. Further, the firm is developing WP1220, an analog of WP1066, intended for topical application in treating cutaneous T-cell lymphoma. Another compound, WP1122, is under development for glioblastoma multiforme and COVID-19. Moleculin Biotech has established collaboration agreements and partnerships with organizations such as MD Anderson, Animal Life Sciences, LLC, and WPD Pharmaceuticals Sp z.o.o. The company was founded in 2015 and maintains its principal offices in Houston, Texas.
Share Price
$0.6155
Last synced: 2026-08-14
Market Cap
$3.28M
Change (1 day)
7.74%
Change (1 year)
-96.39%
Country
US
Trade Moleculin Biotech, Inc. (MBRX)

Category

Stock price history for Moleculin Biotech, Inc. (MBRX)
Highest end of day price: $0.48 on 2026-08-01

Lowest end of day price: $16.17K on 2016-06-01
Stock price history of Moleculin Biotech, Inc. from 2016 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 8.33%
2025 -90.56%
2024 -77.07%
2023 -51.53%
2022 -36.45%
2021 -59.01%
2020 -17.81%
2019 -15.25%
2018 -35.47%
2017 -12.10%
2016 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE